La Jolla names new CFO
This article was originally published in Scrip
San Diego-based La Jolla Pharmaceutical has named Dennis Mulroy chief financial officer. Prior to joining La Jolla, Mr Mulroy was CFO of Taxus Cardium Pharmaceuticals, a publicly traded biotechnology company, since 2005. Before joining Taxus Cardium, Mr Mulroy was CFO of Molecular Imaging and SeraCare Life Sciences and held financial management positions of increasing responsibility at several other companies.